European Commission Expands GSK’s RSV Vaccine Use to Adults 18+
London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
London, United Kingdom, January 26, 2026 — GSK announced that the European Commission (EC) has approved an expanded indication...
London, United Kingdom, January 21, 2026 — GSK has announced a $2.2 billion acquisition of RAPT Therapeutics, securing global...
SAN FRANCISCO | January 9, 2026 — GSK has entered into a five-year strategic collaboration and AI model licensing...
